Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
McKesson
Boehringer Ingelheim
Baxter
Express Scripts

Last Updated: December 7, 2021

Volunteer for clinical trials for PERPHENAZINE at ClinicalTrialExchange

DrugPatentWatch Database Preview

PERPHENAZINE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Perphenazine, and when can generic versions of Perphenazine launch?

Perphenazine is a drug marketed by Pharm Assoc, Ani Pharms, Mylan, Rising, Sandoz, Vintage Pharms, Watson Labs Inc, Wilshire Pharms Inc, Zydus Pharms, Fosun Pharma, Heritage Pharma, Ivax Sub Teva Pharms, Par Pharm, Sun Pharm Industries, and Watson Labs. and is included in forty-seven NDAs.

The generic ingredient in PERPHENAZINE is amitriptyline hydrochloride; perphenazine. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amitriptyline hydrochloride; perphenazine profile page.

Drug patent expirations by year for PERPHENAZINE
Drug Prices for PERPHENAZINE

See drug prices for PERPHENAZINE

Recent Clinical Trials for PERPHENAZINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Berry ConsultantsPhase 3
Jennifer Holder-MurrayPhase 3
European CommissionPhase 1

See all PERPHENAZINE clinical trials

Pharmacology for PERPHENAZINE
Drug ClassPhenothiazine
Medical Subject Heading (MeSH) Categories for PERPHENAZINE
Anatomical Therapeutic Chemical (ATC) Classes for PERPHENAZINE

US Patents and Regulatory Information for PERPHENAZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride; perphenazine TABLET;ORAL 072135-001 Feb 15, 1989 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Heritage Pharma PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride; perphenazine TABLET;ORAL 073008-001 Oct 17, 1991 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Zydus Pharms PERPHENAZINE perphenazine TABLET;ORAL 205232-003 Apr 6, 2020 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Colorcon
Merck
Dow
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.